Hepatocellular carcinoma: evaluation of therapeutic response to interventional procedures

Surgical resection remains the principal curative treatment for hepatocellular carcinoma (HCC) [1]. However, most patients with HCC are not eligible for surgical resection at the time of diagnosis owing to the status of the patients or tumors [2, 3]. In the past decade, a variety of interventional procedures have been employed for the local control of HCC. These include transcatheter arterial chemoembolization (TACE) [4], local ablation techniques using a direct intratumoral injection of compounds such as absolute ethanol [5] or hot saline [6], and thermal ablation techniques such as microwave ablation [7] and radiofrequency (RF) ablation [8]. Precise evaluation with imaging modalities is important to determine whether the tumor is completely treated or needs additional treatment. The information provided by imaging studies is used to estimate prognosis and can modify the treatment plan. Color or power Doppler sonography (US), computed tomography (CT), magnetic resonance imaging (MRI), and angiography have been used for that purpose [9–15]. After successful treatment, the treated lesion is devoid of vascularity on color or power Doppler US and it no longer enhances with contrast material on CT and MRI. When the tumor is not completely treated, residual viable tissue can be detected on Doppler US, CT, and MRI as focal hypervascular foci within the treated lesion [9–11, 14, 15]. For the definite assessment of therapeutic efficacy of interventional procedures, histologic examination using percutaneous needle biopsy may be needed. The procedure, however, is invasive and the specimen retrieved does not always represent the entire lesion owing to sampling errors [15]. Therefore, follow-up imaging studies have been used mostly for that purpose. In this article, we review the imaging findings of HCC treated with interventional procedures and discuss the values and pitfalls of each imaging modality in evaluating therapeutic response.

[1]  J. Bruix,et al.  Treatment of small hepatocellular carcinoma in cirrhotic patients: A cohort study comparing surgical resection and percutaneous ethanol injection , 1993, Hepatology.

[2]  Y. I. Kim,et al.  Therapeutic effect of transcatheter oily chemoembolization therapy for encapsulated nodular hepatocellular carcinoma: CT and pathologic findings. , 1992, Radiology.

[3]  G S Gazelle,et al.  Radio-frequency-induced coagulation necrosis in rabbits: immediate detection at US with a synthetic microsphere contrast agent. , 1999, Radiology.

[4]  H K Lim,et al.  Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: usefulness of power Doppler US with a microbubble contrast agent in evaluating therapeutic response-preliminary results. , 2000, Radiology.

[5]  M. Bernardino,et al.  Contrast-enhanced MR imaging of hepatic lesions treated with percutaneous ethanol ablation therapy. , 1993, Radiology.

[6]  J. Han,et al.  Transarterial chemoembolization through collateral vessels in hepatocellular carcinoma , 1993 .

[7]  M. Hareyama,et al.  Power Doppler sonography: evaluation of hepatocellular carcinoma after treatment with transarterial embolization or percutaneous ethanol injection therapy. , 2000, AJR. American journal of roentgenology.

[8]  O. Matsui,et al.  Hepatocellular carcinoma: CT appearance of parenchymal changes after percutaneous ethanol injection therapy. , 1995, Radiology.

[9]  R. Busuttil,et al.  Current Treatment Modalities for Hepatocellular Carcinoma , 1994, Annals of surgery.

[10]  S Sawada,et al.  Transcatheter oily chemoembolization of hepatocellular carcinoma. , 1989, Radiology.

[11]  F. Garbagnati,et al.  Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. , 1996, AJR. American journal of roentgenology.

[12]  F. Izzo,et al.  Levovist-enhanced Doppler Sonography Versus Spiral Computed Tomography to Evaluate Response to Percutaneous Ethanol Injection in Hepatocellular Carcinoma , 2000, Journal of clinical gastroenterology.

[13]  Y. Yamashita,et al.  CT appearance of hepatic tumors after microwave coagulation therapy. , 1998, AJR. American journal of roentgenology.

[14]  T. Livraghi,et al.  Small hepatocellular carcinoma treated with percutaneous RF ablation: MR imaging follow-up. , 1999, AJR. American journal of roentgenology.

[15]  René M. Botnar,et al.  Radio-frequency-induced thermoablation: monitoring with T1-weighted and proton-frequency-shift MR imaging in an interventional 0.5-T environment. , 1998, Radiology.

[16]  H. Fukuda,et al.  Therapeutic effect of percutaneous ethanol injection on small hepatocellular carcinoma: evaluation with CT. , 1995, Radiology.

[17]  C. Bartolozzi,et al.  Treatment of hepatocellular carcinoma with percutaneous ethanol injection: evaluation with contrast-enhanced MR imaging. , 1994, AJR. American journal of roentgenology.

[18]  Hepatocellular Carcinoma: Use of Color Doppler US to Evaluate Response to Treatment with Percutaneous Ethanol Injection , 1995 .

[19]  C. Bartolozzi,et al.  Hepatocellular carcinoma: CT and MR features after transcatheter arterial embolization and percutaneous ethanol injection. , 1994, Radiology.

[20]  K. Tanikawa,et al.  Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. The liver cancer study group of japan , 1994, Cancer.

[21]  B. I. Choi,et al.  Transcatheter arterial embolization of the internal mammary artery in hepatocellular carcinoma. , 1995, Journal of vascular and interventional radiology : JVIR.

[22]  H. Ueno,et al.  Evaluation of the Therapeutic Effect of Transcatheter Arterial Embolization for Hepatocellular Carcinoma , 2000, Oncology.

[23]  G. Gazelle,et al.  Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance. , 2000, AJR. American journal of roentgenology.

[24]  G. Gazelle,et al.  Tumor ablation with radio-frequency energy. , 2000, Radiology.

[25]  I. Choo,et al.  Transient subsegmental hepatic parenchymal enhancement on dynamic CT: a sign of postbiopsy arterioportal shunt. , 1997, Journal of computer assisted tomography.

[26]  H Uchida,et al.  Percutaneous hot saline injection therapy for hepatic tumors: an alternative to percutaneous ethanol injection therapy. , 1994, Radiology.

[27]  C. Bartolozzi,et al.  Response of Hepatocellular Carcinoma to Percutaneous Ethanol Injection: CT and MR Evaluation , 1993, Journal of computer assisted tomography.

[28]  T. Livraghi,et al.  Radiofrequency thermal ablation of hepatocellular carcinoma. , 2001, European journal of ultrasound : official journal of the European Federation of Societies for Ultrasound in Medicine and Biology.

[29]  M Takahashi,et al.  Treatment of hepatocellular carcinoma: value of percutaneous microwave coagulation. , 1995, AJR. American journal of roentgenology.

[30]  L Solbiati,et al.  Radio-frequency ablation of hepatic metastases: postprocedural assessment with a US microbubble contrast agent--early experience. , 1999, Radiology.

[31]  M. Yoshikawa,et al.  Comparison of CT findings with resected specimens after chemoembolization with iodized oil for hepatocellular carcinoma. , 2000, AJR. American journal of roentgenology.

[32]  J. McGahan,et al.  Hepatic ablation using radiofrequency electrocautery. , 1990, Investigative radiology.

[33]  B. Choi,et al.  Hepatocellular carcinoma: power Doppler US with a contrast agent--preliminary results. , 1998, Radiology.

[34]  C. Bartolozzi,et al.  RADIOFREQUENCY THERMAL ABLATION OF LIVER TUMORS STATE OF THE ART , 2000 .

[35]  D. Woodfield Hepatocellular carcinoma. , 1986, The New Zealand medical journal.